CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 2.36 HKD 2.61%
Market Cap: 3B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

CStone Pharmaceuticals
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CStone Pharmaceuticals
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Total Liabilities
ÂĄ1.1B
CAGR 3-Years
24%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Liabilities
ÂĄ16B
CAGR 3-Years
13%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Liabilities
ÂĄ7.9B
CAGR 3-Years
20%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Liabilities
ÂĄ3B
CAGR 3-Years
47%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Liabilities
ÂĄ23.3B
CAGR 3-Years
27%
CAGR 5-Years
32%
CAGR 10-Years
64%
Imeik Technology Development Co Ltd
SZSE:300896
Total Liabilities
ÂĄ504.4m
CAGR 3-Years
72%
CAGR 5-Years
51%
CAGR 10-Years
N/A
No Stocks Found

CStone Pharmaceuticals
Glance View

Market Cap
3B HKD
Industry
Biotechnology

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Intrinsic Value
2.93 HKD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is CStone Pharmaceuticals's Total Liabilities?
Total Liabilities
1.1B CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Total Liabilities amounts to 1.1B CNY.

What is CStone Pharmaceuticals's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
62%

Over the last year, the Total Liabilities growth was 1%. The average annual Total Liabilities growth rates for CStone Pharmaceuticals have been 24% over the past three years , 62% over the past five years .

Back to Top